Direct coupling of the cell cycle and cell death machinery by E2F
暂无分享,去创建一个
Ramana V. Davuluri | Michael Q. Zhang | Masashi Narita | Yuri Lazebnik | Scott W. Lowe | Y. Lazebnik | S. Lowe | D. Bar-Sagi | R. Davuluri | M. Narita | M. McCurrach | Z. Nahlé | M. Jacobson | Dafna Bar-Sagi | Matthew D. Jacobson | Mila E. McCurrach | Zaher Nahle | Julia Polakoff | J. Polakoff | M. Mccurrach
[1] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[2] B. Pützer,et al. Role of the p53-homologue p73 in E2F1-induced apoptosis , 2000, Nature Genetics.
[3] Charles J. Sherr,et al. The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.
[4] K. Helin,et al. CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase , 1999, Molecular and Cellular Biology.
[5] S. Lowe,et al. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] K. Vousden,et al. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. , 1999, Molecular cell.
[7] D. Bar-Sagi,et al. Suppression of Ras-Induced Apoptosis by the Rac GTPase , 1999, Molecular and Cellular Biology.
[8] J. Nevins,et al. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] Michael Ruogu Zhang,et al. Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. , 2001, Journal of molecular biology.
[10] Y. Lazebnik,et al. Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] Acknowledgements , 1992, Experimental Gerontology.
[12] Joseph B. Rayman,et al. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. , 2000, Genes & development.
[13] B. Franza,et al. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products , 1985, Journal of virology.
[14] S. Lowe,et al. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Baltimore,et al. Autoproteolytic activation of pro-caspases by oligomerization. , 1998, Molecular cell.
[16] A. Levine,et al. p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Franza,et al. Monoclonal Antibodies Specific for Adenovirus Early Region lA Proteins : Extensive Heterogeneity in Early Region 1 A Products , 2022 .
[18] David I. Smith,et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis , 2000, Nature.
[19] Shannon R. Magari,et al. A humanized system for pharmacologic control of gene expression , 1996, Nature Medicine.
[20] Jeffrey M. Trimarchi,et al. Transcription: Sibling rivalry in the E2F family , 2002, Nature Reviews Molecular Cell Biology.
[21] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[22] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[23] J. Beckmann,et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.
[24] K. Tsai,et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. , 1998, Molecular cell.
[25] S. Korsmeyer,et al. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] V. Rivera,et al. Transcriptional squelching re-examined , 1997, Nature.
[27] John T. Powers,et al. ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc , 2002, Molecular and Cellular Biology.
[28] K. Helin,et al. Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.
[29] S. Lowe,et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. , 1999, Science.
[30] José Luis de la Pompa,et al. Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.
[31] N. Dyson. The regulation of E2F by pRB-family proteins. , 1998, Genes & development.
[32] Brent R. Stockwell,et al. An Induced Proximity Model for Caspase-8 Activation* , 1998, The Journal of Biological Chemistry.
[33] Karen H. Vousden,et al. p14ARF links the tumour suppressors RB and p53 , 1998, Nature.
[34] T. Chittenden,et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] F. Christians,et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. , 2001, Genes & development.
[36] C. Harris,et al. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. , 2001, Cancer research.
[37] T. van Dyke,et al. p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo , 2002, Molecular and Cellular Biology.
[38] T. Potter,et al. Adenovirus E1A Oncogene Expression in Tumor Cells Enhances Killing by TNF-Related Apoptosis-Inducing Ligand (TRAIL)1 , 2000, The Journal of Immunology.
[39] S. Lowe,et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.